| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |